Resistance to PI3K/mTOR inhibitor PF-04691502 in KRAS mutant colorectal cancer models reveals a sensitivity to combination with EGFR inhibition
RNA-Seq mRNA differential
Organism:
Mus musculus
Publication:
- Belmont PJ, Jiang P, McKee TD, Xie T, Isaacson J et al. (2014) Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.